Validation of Prostate Cancer Risk Variants by CRISPR/Cas9 Mediated Genome Editing
Xing Wang, James E. Hayes, Xing Xu, Xiaoni Gao, Dipti Mehta, Hans G. Lilja, Robert J. Klein
The paper validates prostate cancer risk SNPs using CRISPR/Cas9 to show they alter MSMB expression, highlighting the importance of functional studies in GWAS findings.
Gene · Oct 26, 2020Peer-reviewedGenetics